tetano
Editor, Senior Moderator
J Cardiothorac Surg
. 2024 Jun 24;19(1):358.
doi: 10.1186/s13019-024-02890-w. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report
Ken Sawada[SUP] 1 [/SUP], Takahiro Kawaji[SUP] 2 [/SUP], Koji Yamana[SUP] 3 [/SUP], Kazuki Matsuhashi[SUP] 3 [/SUP], Yoshitaka Hara[SUP] 1 [/SUP], Naohide Kuriyama[SUP] 1 [/SUP], Tomoyuki Nakamura[SUP] 1 [/SUP], Atsuo Maekawa[SUP] 3 [/SUP], Yasushi Takagi[SUP] 3 [/SUP], Osamu Nishida[SUP] 1 [/SUP]
Affiliations
Background: Infective endocarditis (IE) is a rare cardiovascular complication in patients with coronavirus disease 2019 (COVID-19). IE after COVID-19 can also be complicated by acute respiratory distress syndrome (ARDS); however, the guidelines for the treatment of such cases are not clear. Here, we report a case of perioperative management of post-COVID-19 IE with ARDS using veno-venous extracorporeal membrane oxygenation (V-V ECMO).
Case presentation: The patient was a 40-year-old woman who was admitted on day 18 of COVID-19 onset and was administered oxygen therapy, remdesivir, and dexamethasone. The patient's condition improved; however, on day 24 of hospitalization, the patient developed hypoxemia and was admitted to the intensive care unit (ICU) due to respiratory failure. Blood culture revealed Corynebacterium striatum, and transesophageal echocardiography revealed vegetation on the aortic and mitral valves. Valve destruction was mild, and the cause of respiratory failure was thought to be ARDS. Despite continued antimicrobial therapy, ARDS did not improve the patient's condition, and valve destruction progressed; therefore, surgical treatment was scheduled on day 13 of ICU admission. After preoperative consultation with the team, a decision was made to initiate V-V ECMO after the patient was weaned from CPB, with concerns about further worsening of her respiratory status after surgery. The patient returned to the ICU with transition to V-V ECMO, and her circulation remained stable. The patient was weaned off V-V ECMO on postoperative day 33 and discharged from the ICU on postoperative day 47.
Conclusions: ARDS may occur in patients with IE after COVID-19. Owing to concerns about further exacerbation of pulmonary damage, the timing of surgery should be comprehensively considered. Preoperatively, clinicians should discuss perioperative ECMO introduction and configuration.
Keywords: Acute respiratory distress syndrome; COVID-19; Infective endocarditis; Pulmonary damage; Veno-venous extracorporeal membrane oxygenation.
. 2024 Jun 24;19(1):358.
doi: 10.1186/s13019-024-02890-w. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report
Ken Sawada[SUP] 1 [/SUP], Takahiro Kawaji[SUP] 2 [/SUP], Koji Yamana[SUP] 3 [/SUP], Kazuki Matsuhashi[SUP] 3 [/SUP], Yoshitaka Hara[SUP] 1 [/SUP], Naohide Kuriyama[SUP] 1 [/SUP], Tomoyuki Nakamura[SUP] 1 [/SUP], Atsuo Maekawa[SUP] 3 [/SUP], Yasushi Takagi[SUP] 3 [/SUP], Osamu Nishida[SUP] 1 [/SUP]
Affiliations
- PMID: 38915030
- DOI: 10.1186/s13019-024-02890-w
Background: Infective endocarditis (IE) is a rare cardiovascular complication in patients with coronavirus disease 2019 (COVID-19). IE after COVID-19 can also be complicated by acute respiratory distress syndrome (ARDS); however, the guidelines for the treatment of such cases are not clear. Here, we report a case of perioperative management of post-COVID-19 IE with ARDS using veno-venous extracorporeal membrane oxygenation (V-V ECMO).
Case presentation: The patient was a 40-year-old woman who was admitted on day 18 of COVID-19 onset and was administered oxygen therapy, remdesivir, and dexamethasone. The patient's condition improved; however, on day 24 of hospitalization, the patient developed hypoxemia and was admitted to the intensive care unit (ICU) due to respiratory failure. Blood culture revealed Corynebacterium striatum, and transesophageal echocardiography revealed vegetation on the aortic and mitral valves. Valve destruction was mild, and the cause of respiratory failure was thought to be ARDS. Despite continued antimicrobial therapy, ARDS did not improve the patient's condition, and valve destruction progressed; therefore, surgical treatment was scheduled on day 13 of ICU admission. After preoperative consultation with the team, a decision was made to initiate V-V ECMO after the patient was weaned from CPB, with concerns about further worsening of her respiratory status after surgery. The patient returned to the ICU with transition to V-V ECMO, and her circulation remained stable. The patient was weaned off V-V ECMO on postoperative day 33 and discharged from the ICU on postoperative day 47.
Conclusions: ARDS may occur in patients with IE after COVID-19. Owing to concerns about further exacerbation of pulmonary damage, the timing of surgery should be comprehensively considered. Preoperatively, clinicians should discuss perioperative ECMO introduction and configuration.
Keywords: Acute respiratory distress syndrome; COVID-19; Infective endocarditis; Pulmonary damage; Veno-venous extracorporeal membrane oxygenation.